See also this year's filing and all EDGAR filings for this company.
PDF Report 0001567892_2022_Keenova_Therapeutics_plc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001567892, Keenova Therapeutics plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,309,600,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 5,448,400,000 |
| 2 | PropertyPlantAndEquipmentNet | 776,000,000 |
| 3 | remainder_Assets | 382,300,000 |
| 4 | LiabilitiesCurrent | 1,942,200,000 |
| 5 | LiabilitiesNoncurrent | 85,800,000 |
| 6 | remainder_Liabilities | 6,574,900,000 |
| 7 | CostOfGoodsAndServicesSold | 1,317,100,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 581,800,000 |
| 9 | ResearchAndDevelopmentExpense | 205,200,000 |
| 10 | remainder_Expenses | 851,300,000 |
| 11 | remainder_Revenues | 2,208,800,000 |
| 12 | remainder_NetIncome | 29,200,000 |
| 13 | remainder_ComprehensiveNetIncome | 1,300,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,916,300,000 |
| 1 | Liabilities | 8,602,900,000 |
| 2 | Expenses | 2,955,400,000 |
| 3 | Revenues | 2,208,800,000 |
| 4 | StockholdersEquity | 313,400,000 |
| 5 | NetIncome | -717,400,000 |
| 6 | ComprehensiveNetIncome | -716,750,000 |
| 7 | BaseVar | 11,356,950,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.00383 |
| 9 | EconomicCapitalRatio | 1.41 |